Mapfre


COVID-19 fragility

26/03/20 -"The reduction in our target price was driven by lower earnings for 2020-22 and the increase in the discount, attributed to P/Book, P/E and dividend yield relative to its peers, from 20% to 40%. This ..."

Pages
51
Language
English
Published on
26/03/20
You may also be interested by these reports :
08/04/20
The main headache for Generali is the Life business. For 2020, the insurer should forget the upward trend in both volumes and earnings. The ...

06/04/20
The drop in our EPS was driven by adverse investment variances in the Life businesses. Investment income was historically volatile and the expected ...

02/04/20
With the growing concerns about liquidity, we have decided to cut the final dividend proposed by L&G (£753m). By the end of 2019, cash & cash ...

01/04/20
Munich Re cancelled its profit guidance of €2.8bn for 2020. It’s property-casualty reinsurance segment saw a considerable claims burden from losses ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO